U.S. FDA approves second over-the-counter opioid overdose reversal drug

Open link in next tab

U.S. FDA approves second over-the-counter opioid overdose reversal drug

https://www.cnbc.com/2023/07/28/us-fda-approves-second-over-the-counter-opioid-overdose-reversal-drug.html

The U.S. FDA has approved the second non-prescription opioid overdose reversal drug called "RiVive," a nasal spray version of naloxone.

U.S. FDA approves second over-the-counter opioid overdose reversal drug

The U.S. Food and Drug Administration has approved the prescription-free sale of the second opioid overdose reversal drug, its manufacturer Harm Reduction Therapeutics said on Friday.